184
Views
31
CrossRef citations to date
0
Altmetric
Review

Reappraising the use of β-lactams to treat tuberculosis

&
Pages 999-1006 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Liem Nguyen & Michael R Jacobs. (2012) Counterattacking drug-resistant tuberculosis: molecular strategies and future directions. Expert Review of Anti-infective Therapy 10:9, pages 959-961.
Read now

Articles from other publishers (30)

Sanjay Singh, Tawanda Gumbo, Jan-Willem Alffenaar, Gunavanthi D. Boorgula, Prem Shankar, Tania A. Thomas, Keertan Dheda, Lesibana Malinga, Prithvi Raj, Santosh Aryal & Shashikant Srivastava. (2023) Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen. International Journal of Antimicrobial Agents 62:6, pages 106968.
Crossref
N. Mani, S. Suresh, M. Govindammal, S. Kannan, E. Isac Paulraj, D. Nicksonsebastin & M. Prasath. (2023) Spectroscopic (FT-IR, FT-Raman, NMR and UV–visible), ADMET and molecular docking investigation of aztreonam as anti-tuberculosis agent. Chemical Physics Impact 7, pages 100254.
Crossref
Amala Bhagwat, Aditi Deshpande & Tanya Parish. (2022) How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Alice R. Moorey, Alejandro Cabanillas, Sarah M. Batt, Sonja Ghidelli-Disse, Beatriz Urones, Olalla Sanz, Joel Lelievre, Marcus Bantscheff, Liam R. Cox & Gurdyal S. Besra. (2021) The multi-target aspect of an MmpL3 inhibitor: The BM212 series of compounds bind EthR2, a transcriptional regulator of ethionamide activation. The Cell Surface 7, pages 100068.
Crossref
Sourya Bhattacharya, Vivek Junghare, Niteesh Kumar Pandey, Subhecchha Baidya, Harsha Agarwal, Neeladrisingha Das, Ayan Banerjee, Debashish Ghosh, Partha Roy, Hirak K. Patra & Saugata Hazra. (2021) Variations in the SDN Loop of Class A Beta-Lactamases: A Study of the Molecular Mechanism of BlaC (Mycobacterium tuberculosis) to Alter the Stability and Catalytic Activity Towards Antibiotic Resistance of MBIs. Frontiers in Microbiology 12.
Crossref
Ilona van Alen, Aleksandra Chikunova, Adil A. Safeer, Misbha Ud Din Ahmad, Anastassis Perrakis & Marcellus Ubbink. (2021) The G132S Mutation Enhances the Resistance of Mycobacterium tuberculosis β-Lactamase against Sulbactam . Biochemistry 60:28, pages 2236-2245.
Crossref
Filia Stephanie, Mutiara Saragih & Usman Sumo Friend Tambunan. (2021) Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment. Pharmaceutics 13:5, pages 592.
Crossref
Sarah M. Batt, Christopher E. Burke, Alice R. Moorey & Gurdyal S. Besra. (2020) Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall. The Cell Surface 6, pages 100044.
Crossref
Kimberly E. Beatty. (2020) Fluorescent probes for investigating peptidoglycan biosynthesis in mycobacteria. Current Opinion in Chemical Biology 57, pages 50-57.
Crossref
Mehmet Akif Gun, Bulent Bozdogan & Ahmet Yilmaz Coban. (2020) Tuberculosis and beta-lactam antibiotics. Future Microbiology 15:10, pages 937-944.
Crossref
Wouter Elings, Anamika Gaur, Anneloes J. Blok, Monika Timmer, Hugo van Ingen & Marcellus Ubbink. (2020) β-Lactamase of Mycobacterium tuberculosis Shows Dynamics in the Active Site That Increase upon Inhibitor Binding. Antimicrobial Agents and Chemotherapy 64:3.
Crossref
Vijay Kumar, Simranjeet Singh, Daljeet Singh, Shivika Datta, Sanjay Kumar, Shyam Babu Singh & Joginder Singh. 2020. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery 301 322 .
Landys Lopez Quezada, Kelin Li, Stacey L. McDonald, Quyen Nguyen, Andrew J. Perkowski, Cameron W. Pharr, Ben Gold, Julia Roberts, Kathrine McAulay, Kohta Saito, Selin Somersan Karakaya, Prisca Elis Javidnia, Esther Porras de Francisco, Manuel Marin Amieva, Sara Palomo Dı́az, Alfonso Mendoza Losana, Matthew Zimmerman, Hsin-Pin Ho Liang, Jun Zhang, Veronique Dartois, Stéphanie Sans, Sophie Lagrange, Laurent Goullieux, Christine Roubert, Carl Nathan & Jeffrey Aubé. (2019) Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis . ACS Infectious Diseases 5:8, pages 1433-1445.
Crossref
Matthew Zimmerman, Stacey L. McDonald, Hsin-Pin Ho-Liang, Patrick Porubsky, Quyen Nguyen, Cameron W. Pharr, Andrew J. Perkowski, Robert Smith, Frank J. Schoenen, Ben S. Gold, David Zhang, Carl F. Nathan, Véronique Dartois & Jeffrey Aubé. (2019) Effect of C-2 substitution on the stability of non-traditional cephalosporins in mouse plasma. The Journal of Antibiotics 72:6, pages 469-475.
Crossref
Alyse Wheelock, Eirini Iliaki & Marie T. Turner. (2019) Amoxicillin-Clavulanate in Tuberculosis Disease. Infectious Diseases in Clinical Practice 27:3, pages 126-132.
Crossref
Gerardo Andrés Libreros-Zúñiga, Catharina dos Santos Silva, Rafaela Salgado Ferreira & Marcio Vinicius Bertacine Dias. (2018) Structural Basis for the Interaction and Processing of β-Lactam Antibiotics by l , d -Transpeptidase 3 (Ldt Mt3 ) from Mycobacterium tuberculosis . ACS Infectious Diseases 5:2, pages 260-271.
Crossref
Elena Ufimtseva, Natalya Eremeeva, Sergey Bayborodin, Tatiana Umpeleva, Diana Vakhrusheva & Sergey Skornyakov. (2019) Mycobacterium tuberculosis with different virulence reside within intact phagosomes and inhibit phagolysosomal biogenesis in alveolar macrophages of patients with pulmonary tuberculosis. Tuberculosis 114, pages 77-90.
Crossref
Paul W. Smith, Fabio ZuccottoRobert H. Bates, Maria Santos Martinez-Martinez, Kevin D. Read, Caroline PeetOla Epemolu. (2018) Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future. ACS Infectious Diseases 4:10, pages 1439-1447.
Crossref
Samantha R. Kaplan, Jeffrey Topal, Lynn Sosa, Maricar Malinis, Anita Huttner, Ajay Malhotra & Gerald Friedland. (2018) A patient with central nervous system tuberculomas and a history of disseminated multi-drug-resistant tuberculosis. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 10, pages 9-16.
Crossref
Wouter Elings, Raffaella Tassoni, Steven A. van der Schoot, Wendy Luu, Josef P. Kynast, Lin Dai, Anneloes J. Blok, Monika Timmer, Bogdan I. Florea, Navraj S. Pannu & Marcellus Ubbink. (2017) Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition . Biochemistry 56:47, pages 6257-6267.
Crossref
Joseph S. Cavanaugh, Ruwen Jou, Mei-Hua Wu, Tracy Dalton, Ekaterina Kurbatova, Julia Ershova & J. Peter Cegielski. (2017) Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters. Journal of Antimicrobial Chemotherapy 72:6, pages 1678-1687.
Crossref
Kevin A. Nash. (2016) Multidrug Resistance in Mycobacteria. Current Clinical Microbiology Reports 3:1, pages 53-61.
Crossref
Alain Philippon, Patrick Slama, Paul Dény & Roger Labia. (2016) A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes. Clinical Microbiology Reviews 29:1, pages 29-57.
Crossref
Sebastian G. Kurz, Saugata Hazra, Christopher R. Bethel, Chiara Romagnoli, Emilia Caselli, Fabio Prati, John S. Blanchard & Robert A. Bonomo. (2015) Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) . ACS Infectious Diseases 1:6, pages 234-242.
Crossref
Philippe Egesborg, Hélène Carlettini, Jordan P. Volpato & Nicolas Doucet. (2015) Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from M ycobacterium tuberculosis . Protein Science 24:4, pages 534-544.
Crossref
Xuesong Wu, Yan Zhao & Haibo Ge. (2014) Nickel‐Catalyzed Site‐Selective Amidation of Unactivated C(sp 3 )H Bonds . Chemistry – A European Journal 20:31, pages 9530-9533.
Crossref
Xuesong Wu, Yan Zhao, Guangwu Zhang & Haibo Ge. (2014) Copper-Catalyzed Site-Selective Intramolecular Amidation of Unactivated C(sp 3 )H Bonds . Angewandte Chemie International Edition 53:14, pages 3706-3710.
Crossref
Xuesong Wu, Yan Zhao, Guangwu Zhang & Haibo Ge. (2014) Copper‐Catalyzed Site‐Selective Intramolecular Amidation of Unactivated C(sp 3 )H Bonds . Angewandte Chemie 126:14, pages 3780-3784.
Crossref
Carmen Chow, Hua Xu & John S. Blanchard. (2013) Kinetic Characterization of Hydrolysis of Nitrocefin, Cefoxitin, and Meropenem by β-Lactamase from Mycobacterium tuberculosis . Biochemistry 52:23, pages 4097-4104.
Crossref
Neela Dinesh, Sreevalli Sharma & Meenakshi Balganesh. (2013) Involvement of Efflux Pumps in the Resistance to Peptidoglycan Synthesis Inhibitors in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 57:4, pages 1941-1943.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.